Molecule intelOpportunity: ModerateEssentialUnderserved

Goserelin

2 brands · 1 companies · product forms

ATC: L02AE03

Opportunity snapshot

Launch attractiveness
43
Market saturation
2
Price room
0
Regulatory risk
0
2
brands
1
companies
Rs 27,452.19
median price
1
price points
1x
price spread
50
confidence %

Who competes here

Top companies by brand count — concentrated market · leader share 100%

2 brands · 100%

Price room

Across observed sources and strengths
CheapestRs 27,452.19
MedianRs 27,452.19
Most expensiveRs 27,452.19
Spread1×
Sources: DVAGO, Servaid

Only 1 trusted price points; variation not scored (low data).

Brands & products on the market

Sample of 2 live products for Goserelin — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(85) + 25% price-variation(0) + 20% low-competition(98) + 15% supply-disruption(0), damped by confidence(50). Higher = more attractive, less crowded opportunity.

Market saturation

1 canonical companies and 2 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 1 trusted price points; variation not scored (low data).

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: few brands, sparse price data.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.